Key Findings
Brazilian deeptech company Doroth has successfully secured US$4.51 million in funding to establish Latin America’s inaugural microfluidic chip manufacturing facility. This strategic investment will equip Doroth with the capability to produce up to 4 million microfluidic chips annually, significantly bolstering the regional supply of innovative biosensor technologies. The company’s proprietary lab-on-a-chip technology integrates a diverse array of disciplines, enabling the rapid identification of pathogens, genetically modified organisms (GMOs), and resistance genes in various sample types.
Technical/Clinical Details
Doroth’s lab-on-a-chip technology represents a highly integrated platform, combining molecular biology, microfluidics, engineering, electronics, optics, automation, and software. Microfluidic chips facilitate the automation of analytical processes—including sample preparation, reaction, and detection—on a miniaturized device, effectively condensing complex laboratory procedures into a portable format. Specifically, the rapid detection of pathogens is crucial for infectious disease diagnostics, GMO identification is vital for food safety management, and resistance gene screening contributes to addressing antimicrobial resistance. The new manufacturing plant will enable mass production of these high-precision chips, offering cost-effective solutions and facilitating broader market penetration across various sectors.
Background & Context
Lab-on-a-chip technology has garnered substantial attention for its promise in enabling rapid and portable analysis across diverse fields, including diagnostics, food safety, and environmental monitoring. Historically, the Latin American region has lacked a dedicated manufacturing hub for such advanced microfluidic devices, relying heavily on imports. Doroth’s establishment of a domestic manufacturing facility marks a significant step towards strengthening supply chains, fostering technological independence, and contributing to regional economic growth. The vulnerabilities exposed in global supply chains during the COVID-19 pandemic have further underscored the critical importance of localized technological development and manufacturing to enhance regional resilience.
Strategic Significance & Outlook
The construction of Doroth’s microfluidic chip manufacturing plant is a landmark event for the biotechnology industry in Brazil and Latin America. An annual production capacity of 4 million chips will open doors for applications not only in the diagnostic device market but also in agriculture, veterinary medicine, and food processing. This investment is a crucial step for the company to address regional needs and enhance its competitiveness in the international market. In the long term, this manufacturing base is expected to become an innovation hub for the Latin American region, fostering further research and development and creating opportunities for technology export. Doroth’s success will invigorate the regional deep-tech ecosystem and accelerate the widespread adoption of advanced biosensor technologies.
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
Comments